Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Pennsylvania
With
Aetna, Inc.
Age
21–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
21 years old age or older
On warfarin managed at the AC clinic
Target INR 2.0-3.0 or 2.5-3.5
At maintenance phase of therapy (defined as stable INR with stable warfarin dosing over at least 2 consecutive visits)
You may not be if
Do not have access to telephone line
Unwillingness to participate or to sign a consent form(refusal)
Inability to participate because of advances dementia, advanced Alzheimer's disease or other impairment affecting ability to provide informed consent and/or quality data or utilize the Med-eMonitor
Participation in a current study that does not permit participation in another study
End stage or terminal illness with anticipated life expectancy of 6 months or less
INR over the upper limit for the individual's range at the time of enrollment (e.g.,\>3.0 or \>3.5, depending on the target range)
Diagnosed with antiphospholipid antibody syndrome or abnormal INR prior to starting warfarin
Clareo Health | Testing Strategies to Improving Warfarin Adherence
